Knoa Pharma Overview

  • Year Founded
  • 1892

Year Founded

  • Status
  • Private

  • Employees
  • 922

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

  • Financing Rounds
  • 2

  • Investments
  • 9

Knoa Pharma General Information

Description

Developer of medications and consumer health products intended to meet the needs of healthcare professionals, patients, consumers, and caregivers. The company is primarily into the development of formulations containing opioid agonists such as oxycodone, morphine, buprenorphine, and hydrocodone for pain relief purposes, along with laxatives, antiseptics, dietary supplements, and an injectable drug for opioid overdose.

Contact Information

Formerly Known As
The Purdue Frederick, Purdue Pharma
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • One Stamford Forum
  • 201 Tresser Boulevard
  • Stamford, CT 06901-3431
  • United States
+1 (203)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • One Stamford Forum
  • 201 Tresser Boulevard
  • Stamford, CT 06901-3431
  • United States
+1 (203)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Knoa Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Knoa Pharma‘s full profile, request access.

Request a free trial

Knoa Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medications and consumer health products intended to meet the needs of healthcare professionals, patients,
Drug Discovery
Stamford, CT
922 As of 2025

Basel, Switzerland
 

Osaka, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Knoa Pharma Competitors (55)

One of Knoa Pharma’s 55 competitors is Novartis, a Corporation company based in Basel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis Corporation Basel, Switzerland
Shionogi Corporation Osaka, Japan
Johnson&Johnson Innovative Medicine Venture Capital-Backed Raritan, NJ
Hoechst Pakistan Corporate Backed or Acquired Karachi, Pakistan
Evonile Pharma Private Equity-Backed Mumbai, India
You’re viewing 5 of 55 competitors. Get the full list »

Knoa Pharma Patents

Knoa Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024402318-A1 Autoinjector for opioid overdose rescue Pending 21-Dec-2023
EP-4827961-A1 Autoinjector for opioid overdose rescue Pending 21-Dec-2023
JP-2026533031-A Snobinop for use in the treatment of alcohol use disorder Pending 19-Oct-2023
AU-2024364388-A1 Sunobinop for use in method of treating alcohol use disorder Pending 19-Oct-2023
EP-4794697-A1 Sunobinop for use in method of treating alcohol use disorder Pending 19-Oct-2023 A61K31/498
To view Knoa Pharma’s complete patent history, request access »

Knoa Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Knoa Pharma Investments & Acquisitions (9)

Knoa Pharma’s most recent deal was a Later Stage VC with Frenelle Pharma for . The deal was made on 28-Aug-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Frenelle Pharma 28-Aug-2018 Later Stage VC Drug Discovery
CognifiSense 02-Feb-2018 Grant Therapeutic Devices
VM Pharma (TrkA Program) 08-Sep-2015 Corporate Asset Purchase Buildings and Property
Kolltan Pharmaceuticals 17-Mar-2014 Later Stage VC Drug Discovery
NASCSA 23-Oct-2012 Grant Media and Information Services (B2B)
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Knoa Pharma Exits (4)

Knoa Pharma’s most recent exit was on 17-Mar-2014 from Kolltan Pharmaceuticals. The exit was categorized as with 12 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Kolltan Pharmaceuticals 17-Mar-2014 Completed
  • 12 buyers
Infinity Pharmaceuticals 01-Jul-2012 Completed
  • 2 buyers
Kolltan Pharmaceuticals 18-Aug-2009 Completed
  • 9 buyers
Optherion 09-Oct-2007 Early Stage VC Completed
  • 7 buyers
To view Knoa Pharma’s complete exits history, request access »

Knoa Pharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
CoCensys Irvine, CA 1989

Knoa Pharma FAQs

  • When was Knoa Pharma founded?

    Knoa Pharma was founded in 1892.

  • Where is Knoa Pharma headquartered?

    Knoa Pharma is headquartered in Stamford, CT.

  • What is the size of Knoa Pharma?

    Knoa Pharma has 922 total employees.

  • What industry is Knoa Pharma in?

    Knoa Pharma’s primary industry is Drug Discovery.

  • Is Knoa Pharma a private or public company?

    Knoa Pharma is a Private company.

  • What is Knoa Pharma’s current revenue?

    The current revenue for Knoa Pharma is .

  • Who are Knoa Pharma’s competitors?

    Novartis, Shionogi, Johnson&Johnson Innovative Medicine, Hoechst Pakistan, and Evonile Pharma are some of the 55 competitors of Knoa Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process